Renub Research report titled “Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application, Companies” captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future. Global Biopsy Device Market is anticipated to surpass USD 2.8 Billion by the year end of 2025.
Biopsy refers to surgical removal of a tissue from any human organ in order to know the existence of a particular cancer disorder. This procedure is performed by surgeons, cardiologists and radiologists. The use of each biopsy tool can vary depending on the type of organ being considered.
The main factor driving market growth is minimal invasive surgery which mitigates risks and side effects. In addition, increasing awareness about chronic disease diagnosis increases demand for advanced biopsy technologies such as stereotactic-guided biopsy. Nevertheless, high biopsy procedure costs and limited availability of skilled professionals in low-income countries are hampering market growth.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php
Biopsy was one of the main cancer disease screening methods and is commonly used in breast, hair, and prostate cancer diagnosis. According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Therefore, the market is expected to increase with the rising incidence of cancer cases and advancements in biopsy devices.
Most countries have services for early breast cancer detection. These policies will therefore increase the rate of adoption of biopsy devices and thus have a positive impact on the development of the industry of biopsy devices in the foreseeable future.
By Segments: The product-based demand for biopsy devices is categorized into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and kits and others. The needle-based biopsy tools gained the largest market share of biopsy products in 2018. This segment is also expected to grow at the fastest rate in the forecast period due to an increase in breast cancer, gastrointestinal tract diseases and soft tissue sarcomas.
By Application: Breast biopsy in the product segment which has produced the highest revenue in 2018 and is expected to maintain its dominance over the forecast period, according to the report. This is due to an increase in the number of patients with breast cancer who have been observed across the globe over the years and are expected to continue this trend in the future.
By Regions: Due to the high availability of trained medical professionals, the existence of well-developed infrastructure facilities and the presence of a number of key players, North America holds the largest market share in 2018 and is expected to maintain its dominance during the forecast period.
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Browse Related Reports :
Key Topics Covered :
2. Research Methodology
3. Executive Summery
4. Global – Biopsy Devices Market
5. Market Share – Global Biopsy Devices
5.1 By Product
5.2 By Application
5.3 By Region
5.4 By End-User
6. By Product – Biopsy Devices Market
6.1 Biopsy Needles
6.2 Guidance Systems
6.3 Biopsy Guns
6.4 Reagents and kits
6.5 Others (Brushes, Curettes and Punches etc)
7. By Application – Biopsy Devices Market
7.1 Breast Biopsy
7.2 Lung Biopsy
7.3 Prostate Biopsy
8. By Region – Biopsy Devices Market
8.1 North America
8.4 Rest of World
9. By End – User – Biopsy Devices Market
9.1 Diagnostic Center
9.4 C. R. Bard, Inc. – Company Analysis
9.6 Merger & Acquisition
9.7 Financial Insight
10. Becton, Dickinson and Company – Company Analysis
10.2 Key Devlopments
10.3 Merger & Acquisition
10.4 Financial Insight
11. B. Braun Melsungen AG – Company Analysis
11.2 Key Devlopments
11.3 Merger & Acquisition
11.4 Financial Insight
12. Cardinal Health, Inc. – Company Analysis
12.2 Key Devlopments
12.3 Merger & Acquisition
12.4 Financial Insight
13. Olympus Corporation – Company Analysis
13.2 Key Devlopments
13.3 Merger & Acquisition
13.4 Financial Insight
14. Boston Scientific Corporation – Company Analysis
14.2 Key Developments
14.3 Merger & Acquisition
14.4 Financial Insight
15. Medtronic plc – Company Analysis
15.2 Key Devlopments
15.3 Merger & Acquisition
15.4 Financial Insight
16. Hologic, Inc. – Company Analysis
16.2 Key Developments
16.3 Merger & Acquisition
16.4 Financial Insight
17. Growth Drivers
17.1 Inadequate Screening Tests for Particular Cancers
17.2 Demand for Minimally-Invasive Biopsy Technique
17.3 Advancement in Biopsy Techniques
18.1 Breast Biopsy Reimbursement Bundling
18.2 Biopsy Limitations
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Address:225 Kristie Ln
Country: United States